Dan Foltz, PhD, professor of Biochemistry and Molecular Genetics, has been named director of the Walter S. and Lucienne Driskill Graduate Program in Life Sciences (DGP). He will begin the role on July 1.
Feinberg’s Medical Faculty Council (MFC) honored the recipients of the 2024 Mentor of the Year awards at a workshop on May 29, with awardees sharing insights from their experiences mentoring students, trainees and peers.
As GLP-1 receptor agonist medications like semaglutide have been shown to be effective at helping patients lose weight, scientists are now asking, whether they can treat other conditions where obesity is a risk factor. Most recently, initial studies have shown that they can reduce the risk of cardiovascular disease by reducing overall body weight.
In the last several years, anti-obesity medications have made an impression through wide media coverage and interest in their effectiveness. Feinberg investigators have been leading research on these drugs for the treatment of obesity and advocating for access to these medications for the patients who need it most.
Mary Kwasny, ScD, professor of Preventive Medicine in the Division of Biostatistics, has received the American Statistical Association’s (ASA) Founders Award, the highest award the organization bestows for distinguished service.
The Breakthroughs podcast released 19 episodes in 2023 on topics ranging from implementation science and ChatGPT to new insights in dopamine and AI in healthcare. The top three most downloaded episodes this year were on varying topics including exercise and Parkinson’s disease, food allergies and recent discoveries about mitochondria.
Since the COVID-19 pandemic thrust many providers into telehealth appointments, scientists have been asking questions about the benefits and concerns of telehealth. While telehealth was in use and gathering interest prior to the pandemic, the need for it accelerated during a time when people were encouraged to stay home.
Twelve Feinberg faculty members were named to the 2023 “Highly Cited Researchers” list, published by Clarivate Analytics. The annual list identifies investigators who have demonstrated significant influence in their field through the publication of highly cited publications during the last decade.
Feinberg principal investigators secured $706 million in research funding and awards during the 2022-23 fiscal year, which is a nearly nine percent increase over the previous year, and the largest amount in the school’s history.
David Cella, PhD, professor of Medical Social Sciences, has been named the winner of the 2023 Tripartite Legacy Faculty Prize in Translational Science and Education.